ALG13 X‐linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes is a research paper published in Journal of Inherited Metabolic Disease (2021). On theSindex it has a DataRank of 0. It has been cited 29 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01DK99551
National Institutes of Health
Grant: T32 GM008638
National Institutes of Health
Grant: U54 NS115198
NIDDK NIH HHS
Grant: R01 DK099551
NHGRI NIH HHS
Grant: UM1 HG006504
NCATS NIH HHS
Grant: UL1 TR001863
NHGRI NIH HHS
Grant: U24 HG008956
NHLBI NIH HHS
Grant: R00 HL143036
National Institutes of Health
Grant: 5R01DK099551-04
New Congenital Disorders of Glycosylation: Therapy and Models
National Institutes of Health
Grant: 5U24HG008956-02
NHGRI Genome Sequencing Program Coordinating Center
National Institutes of Health
Grant: 5UM1HG006504-07
Yale Center for Mendelian Genomics
National Institutes of Health
Grant: 2T32GM008638-16
Medical Genetics Research Training Grant
National Institutes of Health
Grant: 5U54NS115198-04
Frontiers in Congenital Disorders of Glycosylation
Wellcome Trust
National Human Genome Research Institute
Department of Health, Australian Government
State Government of Victoria
National Institute for Health Research (NIHR)
Wellcome Trust
FWCI
1.26
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Congenital disorders of glycosylation (CDG): state of the art in 2022
Additional file 1 of Congenital disorders of glycosylation (CDG): state of the art in 2022